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1024-163 Influence of Poverty on Process of Care and Outcome 
in Acute Coronary Syndromes 
Sunil v. Rao. Padma Kaui, Kristin Newby, Robed A. Harrington, Daniel B, Mark, Eric D. 
Peterson, Duke Clinical Research Institute, Durham, North Carolina. 
Background: Observational studies have suggested that low-income patients have 
higher mortality after MI, attributing this to higher baseline risk or lower access to care. It 
is unclear whether patient income can affect process of care and/or outcomes within the 
context of a clinical trial, 
Methods: We compared use of catheterization, revascularization, & medical therapy 
among low-income patients (LI) (annual income < $10,000) versus higher income 
patients enrolled in the economic substudy of the U,S. PURSUIT trial (n=2207). After 
controlling for patient clinical risk, we assessed the influence of income on mortality using 
a previously validated mortality model (c-index=0.81). 
Results: Overall 22% of our cohort had income levels < $10,000. LI patients were more 
likely to be female, older, and have HTN, diabetes, and CHF, & less likely to undergo 
revascularization. LI patients had higher 30-day and 6-month mortality. These differences 
in outcome persisted after adjusting for baseline risk, medications, & use of revascular- 
ization (Table). 
Conclusions: Even in a clinical trial setting where many care processes are standard- 
ized, patient socioeconomic status strongly affects shod and long-term outcomes. These 
results indicate that more studies are necessary to identify prognostic factors associated 
with poverty. Furthermore, initiatives designed specifically to eliminate disparities in 
health care are needed. 
Odds ratios and 95% CI for 30-day and 6-month Mortality 
Outcome Unadjusted OR Adjusted OR 
30-day mortality 2.679 (1.547, 4.638) 1.969 (1.048, 3.699) 
6-month mortality 2.079 (1.339, 3.227) 1.552 (0.934, 2.579) 
1024-164 The Willingness of Under-Represented Groups to  
Participate in Clinical Trials 
Eric D. Paterson, Barbara L. Lytle, Karen P. Alexander, Laura P. Coombs, Duke Clinical 
Research Institute, Durham, North Carolina. 
Background: Women, the elderly, and minorities have been underrepresented in cardiac 
randomized clinical trials (RCTs). It is unclear whether differences in patients' willingness 
to consider participating in RCTs explain this low enrollment. 
Methods: From 7/00-3/01, we presented 663 CAD patients undergoing catheterization at 
Duke with options to participate in two hypothetical RCTs: a PCI versus medicine RCT 
and a CABG versus medicine RCT. Patients rated their willingness to participate in each 
on a 5-point Liked scale. Multivariable logistic regression was used to determine predic- 
tors of affirmative responses ("definitely/probably" participate), Our sample included 35% 
women; 43% age ->70; and 22% non-white. 
Results: Women were significantly less likely than men to agree to participate in either 
the PCI (37% vs 47%; p=.02) or CABG RCT (25% vs 37%; p=.002). In contrast, the eld- 
erly (->70 years) and non-whites had similar or higher willingness to consider the PCI and 
CABG RCTs than their counterparts. Table 1 displays the multivariable OR for agreement 
to consider participating in a RCT adjusted for age, race, education-level, and other clini- 
cal factors. 
Conclusion: Despite low historical RCT enrollment, our study suggests that the elderly 
and minority CAD patients have similar or greater willingness to consider RCT participa- 
tion as their counterparts. Further investigation is needed to determine the reasons why 
women are more reluctant than men to participate in cardiac RCTs. 
PCI RCT CABG RCT 
OR (95% CI) OR (95% CI) 
Women 0.65 (0.47, 0.91) 0.56 (0.39, 0.80) 
Age >70 1.31 (0.95, 1.80) 1.30 (0.93, 1.83) 
Non-white 1.22 (0.82, 1.60) 0.95 (0.64, 1.44) 
1024-165 Implementation of the American College of Cardiology 
and the American Heart Association's Guidelines for 
Preoperative Cardiac Risk Assessment in a General 
Medicine Preoperative Clinic: Improving Efficiency and 
Preserving Outcomes 
Yassar Almanaseer. Rajendra H. Mehta, Sean K, Kesterson, Ssema Sonned, Bruce 
Rogers, Dean E. Smith, Scott Fumey, Rob Ernst, Jane McCort, Kim A. Eagle, University 
of Michigan, Ann Arbor, Michigan. 
Background: The ACC/AHA guidelines for cardiac assessment of noncardiac surgery 
were published in 1996 with the intent of promoting evidence based, efficient, preopera- 
tive screening and preoperative management in patients having noncardiac surgery. We 
sought to study the impact of guideline implementation in a general internal medicine 
preoperative clinic, 
Methods: Baseline records of 299 consecutive patients from the preoperative clinic seen 
prior to guideline publication were reviewed. We compared the care, and the outcomes of 
these to 339 consecutive patients studied after the guideline was implemented in our 
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clinic. Guideline implementation included a series of grand rounds for faculty, dissemina- 
tion of a guideline pocket card to faculty and housestaff, creation of a clinic note which 
emphasized guideline-based decisions, and a monthly case conference with faculty and 
residents. We examined demographics, type of surgery, preoperative stress test (ETT), 
preoperative cardiac consults, perioperative B-Blocker therapy, length of stay (LOS) and 
, compared pre-guideline to post-guideline patients. 
Result: Age, gender, past medical history were comparable in the two groups. E'IT 
(30.8% Versus 16.2%, P<0.0001) and LOS (6.5 Versus 5.6 days, P= 0.055) were 
reduced after the guideline implementation. Test appropriateness (86% Versus 94.1%, 
P=0.0005), and utilization of B-Blocker therapy (15.7% Versus 34.5%, P<O.0001) were 
increased following the introduction of the guideline. Perioperative MI and cardiac death 
rates were similady low in each period (one cardiac death in each). 
Conclusion: It is possible to implement the ACC/AHA guidelines for preoperative car- 
diac dsk assessment in a general medicine preoperative clinic by utilizing simple tools 
used at the point of service as well as sustained educational efforts. The guideline-based 
approach is more efficient, leads to more appropriate testing, and preserves a low rate of 
perioperative cardiac complications. 
1024-166 Efficacy of Participatory Education as Compared to 
Clinical Guidelines in Secondary Prevention of Patients 
With Coronary Artery Disease: A Randomized Study 
Anna Kiessling, Peter Henriksson, Karolinska Institute, Stockholm, Sweden. 
Background:To compare efficacy at patient level of a modified Case method intervention 
with participatory education in secondary prevention of CAD for General Practitioners 
(GP's) as compared to conventional clinical guidelines as a method of reducing the gap 
between evidence based goals and what is presently achieved in clinical practice. 
Methods: A prospective randomized controlled trial at Soded&lie Hospital and its 14 Pri- 
mary Health Care Centers (PHCC). Local clinical guidelines were presented to all GP's. 
PHCC's were matched into equal pairs with 26 respectively 28 GP's and randomized into 
intervention (I) respectively control (C).The I group participated in 3-4 recurrent interac- 
tive Case seminars at their own PHCC. A locally well-known opinion leader (cardiologist) 
served as facilitator. 236 consecutive CAD-patients <71 yrs, were included. 166 males/ 
52 females, 80±7 yrs, cholesterol 6.4±1.1 and LDL-cholesterol 4.2±1.0 (mmol/1). 209 pts 
completed the study. Outcome assessment was change in pt lipid levels after two yrs 
analyzed according to intention-to-treat. 
Results: There were no significant differences between t and C concerning demographic 
factors, lipid levels or functional state at baseline. After two years pts treated by GP's in 
the I group had their LDL-cholesterol reduced by 9.3±3.5%, while pts treated by GP's in 
the C group who had only received conventional information and clinical guidelines had 
no change in their LDL--cholesterol (0.6±2.9%). Pts treated at the specialist clinic had 
their LDL-cholesterol reduced by 12.4±1.8% during the two years (p=0.0013 ; ANOVA). 
Conclusion: Conventional introduction of clinical guidelines had no effect on the GP's 
behavior as assessed by change in pt cholesterol. This lack of change in control pts was 
found in spite of the presentation of the results from the 4-S trial at the beginning of the 
study. Participatory education based on the Case method for GP's resulted in a lipid low- 
ering in their CAD pts quite comparable to what was achieved at a specialist clinic. Thus, 
we would strongly question the impact on patient outcome of clinical guidelines per se, 
and advocate complementary methods aimed at attitude and behavioral change of physi- 
cians. 
1024-167 The Expected Rate of Normal Coronary Arteriogrems in 
the Cardiac Laboratory 
Ben D. McCallister, Leelee J. Shaw, Kristi R. Mitchell, Michael J. Wolk, Lloyd W. Klein, 
William S. Weintraub, Ralph G, Brindis, ACC-NCDR Writing Group, Bethesda, Maryland. 
Background: The rate of normal coronary artedograms(NCA) is an important measure of 
quality in the Cardiac Catheterization Laboratory (CCL), as noted in the 2001 ACC/SCAI 
Consensus Statement on CCL Standards. Rates in the literature have varied from 9-36% 
(av = 21%), in part related to differences in definitions and the pre-test likelihood of dis- 
ease. 
Methods: We examined the clinical and coronary stenosis (CS) findings in patients (pts) 
who had a diagnostic CA(DCA) for either no chest pain (OCP) or atypical chest pain 
(ATP) in the ACC/NCDR database of 195,256 pts. 
Results: There was no relation between the rates of NCA to hospital volume of DCA 
(range in r value = 0.027-0.077; p=0.000t), Significant multivariable negative predictors 
of a NCA were the usual CV risk factors (all p<0.0001; model Chi Sq = 6430; p<0.0001). 
The only + predictor was OCP or ATP (odds ratio = 2.29, 95% CI =2.16-2.44, 
p=<0.O001). 
Conclusion: This study clearly identifies that the variable rate of NCA in pts undergoing 
DCA is related to differences in pt mix and the definition of a NCA. It is important hat for 
CCL quality measurement, that comparable pts need to be benchmarked with a standard 
definition of a "NCA', (i.e. 0% CS vs, <50% CS) and comparing the population of only pts 
with OCP or ATP who have had DCA. DCA done in hospitals with a higher or lower mix 
of valvular heart disease, typical or unstable angina, pnor CABG and PCI, or recent or 
remote myocardial infarction will have substantially different rates of NCA. 
Observed Rates of %Normal Coronary Arterlogram 
Pt Grp #" 0% CS 95% CI p<0.0001 <50% CS 95% CI p=<0.0001 
OCP 9896 39.7 38.8-40.6 51.6 50,7-52.5 
ATP 11448 54.5 53.6-55.4 69.7 59.8-70.5 
Combined 21344 47.6 46.9-48.5 61.3 60,6-62.0 
